New insights into the physiology and pharmacology of vitamin C

CMAJ. Canadian Medical Association Journal

Volumn 164, Issue 3, 2001, Pages 353-355

  Padayatty, S J ^a   Levine, M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID;

DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG EXCRETION; DRUG PROTEIN BINDING; HUMAN; NOTE; STEADY STATE;

EID: 0035814732     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (16)

1. Experimental scurvy in man
2. Lind's treatise on scurvy
3. Vitamin C pharmacokinetics in healthy volunteers: Evidence for a recommended dietary allowance
4. Vitamin C status of an outpatient population
5. Criteria and recommendations for vitamin C intake
6. A family of mammalian Na+-dependent L-ascorbic acid transporters
7. Absorption, transport, and disposition of ascorbic acid in humans
8. Pharmacokinetic model of ascorbic acid in healthy male volunteers during depletion and repletion
9. Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent
10. Differential effects and transport kinetics of ascorbate derivatives in leukemic cell lines
11. The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer
12. Supplemental ascorbate in the supportive treatment of cancer: Reevaluation of prolongation of survival times in terminal human cancer
13. Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer
14. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison
15. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial
16. National Cancer Institute's evaluation of unconventional cancer treatments